PRTN3 and rheumatoid arthritis: Considering that the effect of ACPAs can be mediated either through the direct binding of Fab to antigens or through Fc receptor signaling, efforts have been made to clarify the underlying mechanisms and validate ACPA-mediated osteoclast activities in RA-associated symptoms.